Behavior of risk factors of cerebrovascular diseases, Pedras, Maranhão Brazil
Keywords:
risk factors, cerebrovascular diseaseAbstract
A retrospective descriptive study was conducted in the from November 2016 to August 2017, in order to determine the main risk factors that cause the cerebrovascular diseases in the Basic Health Unit of Pedras municipality Matões do Norte Maranhão, Brazil. The studied universe was 218 patients aged 50 years and over. The source of data collection was a tab designed by the author through the review of individual and family medical records. The variables were studied: age, sex, race, family history of cerebrovascular disease (CVD), modifiable risk factors and the association of risk factors. The age group from 70 to 79 years and the male sex, as well as miscegenation in patients, the main modifiable risk factors were arterial hypertension and smoking, 40.3% presented 3 or more risk factors. Conclusions and recommendations are issued.Downloads
Download data is not yet available.
References
1. Tunstall-Pedoe H. Cardiovascular risk and risk scores: ASSIGN, Framingham, QRISK and others: howtochoose. Heart. 2011; 97:44-24.
2. Torres Damas EL, Expósito Torres YE, Zapata Huete LA, Bustillo Santandreu MJ, San Blas Valdés JA. Factores de riesgo aterogénicos en población adulta del policlínico "José R. León Acosta". Rev Cub Angiol Cir Vasc [Internet]. 2010 [citado 18 abr 2013]; 11(1):46-48. Disponible en: http://bvs.sld.cu/revistas/ang/vol11_01_10/ang07110.htm
3. Ministerio de Salud Pública. Situación de Salud en Cuba. Indicadores Básicos. La Habana: Dirección Nacional de Registros. Médicos y Estadísticas de Salud; 2011 [citado 9 may 2012]. Disponible en: http://www.sld.cu/sitios/dne/
4. OMS. Las diez causas principales de defunción. [Internet] 2004 [citado 10 de marzo de 2015]. Disponible en: http://www.who.int/mediacentre/factsheets/fs310/es/
5. Coutin Marie G. El control de la HTA puede incrementar la esperanza de vida. Verificación de una hipótesis. Rev Cubana Med [Internet]. 2001 [citado 10 de marzo de 2015]; 40(2):103-8. Disponible en: http://www.bvs.sld.cu/revistas/med/vol40_2_01/med03201.htm
6. The Editors. Circulation Research Thematic Synopsis: Atherosclerosis. Circulation Res [Internet]. 2013 [citado 2017 May 10]; 112: e118-e147. Disponible en: http://www.cdc.gov/nchs/fastats/heart.html
7. Paraskevas KI, Bessias N, Papas TT, Gekas CD, Andrikopoulos V, Mikhailidis DP. Do different vascular risk factors affect all arteries equally? Angiology. 2008; 59 (4): 397-401.
8. Krishnamurthi R, Feigin V, Forouzanfar M, Mensah G, Connor M, Bennet tD. Global and regional burdenoffirst-everis chaemic and haemorrhagic stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. The Lancet Global Health. 2013; 185:259-e281 doi: 10.1016/S2214-109X(13)70089
9. Álvarez Prats M, Triana Mantilla ME. El ácido úrico y su capacidad de ser o no un factor de riesgo de enfermedad vascular. Rev Cubana Angiol Cir Vasc [Internet]. 2013 [citado 10 nov 2017]; 14(2): [aprox. 14 p.]. Disponible en: http://bvs.sld.cu/revistas/ang/vol14_2_13 /ang05213.htm
10. Haheim LL, Holme I, Hjermann I, Leren P. Riskfactors of stroke incidence and mortality: a 12 yearfollow-up of the Oslo study. Stroke. 2013; 24(10):1484-9.
11. Nagaraj SK, Pai P, Bhat G, Hemalatha A. Lipoprotein (a) and other lipid profile in patient swith thrombotic stroke: Isit a reliablemarker? J Lab Physicians. 2011; 3(1):2832.
12. LU H, Daugherty A. Atherosclerosis: cell biology and lipoproteins. Curr Opin Lipidol. 2011; 22:322-3.
13. Edjoc RK, Reid RD, Sharma M. Thee effectiveness of smoking cessation interventions in smokers with cerebrovascular disease: a systematic review. BMJ Open [Internet]. 2012 [citado 2017 Abr 19]; 2012(2):e002022. Disponible en: http://dx.doi.org/10.1136/bmjopen-2012-002022
14. Fowkes FG, Murray GD, Butcher I, Heald CL, Lee RJ, Chambless LE, et al. Ankle Brachial Index Collaboration. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA. 2013; 300:197-208.
15. Leyva Pérez Y, Soria Pérez R, Merencio Leyva N, Enamorado Suárez E, Herrera López Y. Caracterización clínico-epidemiológica de las enfermedades cerebrovasculares en el municipio Mayar. CCM. 2012 [citado 8 nov 2017]; 17(1): [aprox. 19 p.]. Disponible en: http://www.revcocmed.sld.cu/index.php/cocmed /article/viewFile/279/249
16. Ärnlöv J, Ingelsson E, Sundström J, Lind L. Impact of bodymassindex and the metabolic syndrome on the risk of cardiovascular disease and death in middle –aged men. Circulation. 2010; 121:230-6.
17. Lavados PM, Sacks C, Prina L, Escobar A, Tossi C, Araya F, et al. Prevalencia y factores de riesgo asociados a enfermedad cerebrovascular. Chile: a 2 year community based prospective study (PISCIS project). Lancet. 2015 [citado 8 nov 2017]; 365 (9478):2206-15.
18. Roiz Balaguer M, Morales Barrab I. Mortalidad por enfermedad cerebrovascular en el Hospital Julio Trigo López 2006. Rev Hab Cienc Med [Internet]. 2010 [citado 8 nov 2017]; 9 (1):19-26. Disponible en: http://scielo.sld.cu/pdf/rhcm/v9n1/rhcm05110.pdf
2. Torres Damas EL, Expósito Torres YE, Zapata Huete LA, Bustillo Santandreu MJ, San Blas Valdés JA. Factores de riesgo aterogénicos en población adulta del policlínico "José R. León Acosta". Rev Cub Angiol Cir Vasc [Internet]. 2010 [citado 18 abr 2013]; 11(1):46-48. Disponible en: http://bvs.sld.cu/revistas/ang/vol11_01_10/ang07110.htm
3. Ministerio de Salud Pública. Situación de Salud en Cuba. Indicadores Básicos. La Habana: Dirección Nacional de Registros. Médicos y Estadísticas de Salud; 2011 [citado 9 may 2012]. Disponible en: http://www.sld.cu/sitios/dne/
4. OMS. Las diez causas principales de defunción. [Internet] 2004 [citado 10 de marzo de 2015]. Disponible en: http://www.who.int/mediacentre/factsheets/fs310/es/
5. Coutin Marie G. El control de la HTA puede incrementar la esperanza de vida. Verificación de una hipótesis. Rev Cubana Med [Internet]. 2001 [citado 10 de marzo de 2015]; 40(2):103-8. Disponible en: http://www.bvs.sld.cu/revistas/med/vol40_2_01/med03201.htm
6. The Editors. Circulation Research Thematic Synopsis: Atherosclerosis. Circulation Res [Internet]. 2013 [citado 2017 May 10]; 112: e118-e147. Disponible en: http://www.cdc.gov/nchs/fastats/heart.html
7. Paraskevas KI, Bessias N, Papas TT, Gekas CD, Andrikopoulos V, Mikhailidis DP. Do different vascular risk factors affect all arteries equally? Angiology. 2008; 59 (4): 397-401.
8. Krishnamurthi R, Feigin V, Forouzanfar M, Mensah G, Connor M, Bennet tD. Global and regional burdenoffirst-everis chaemic and haemorrhagic stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. The Lancet Global Health. 2013; 185:259-e281 doi: 10.1016/S2214-109X(13)70089
9. Álvarez Prats M, Triana Mantilla ME. El ácido úrico y su capacidad de ser o no un factor de riesgo de enfermedad vascular. Rev Cubana Angiol Cir Vasc [Internet]. 2013 [citado 10 nov 2017]; 14(2): [aprox. 14 p.]. Disponible en: http://bvs.sld.cu/revistas/ang/vol14_2_13 /ang05213.htm
10. Haheim LL, Holme I, Hjermann I, Leren P. Riskfactors of stroke incidence and mortality: a 12 yearfollow-up of the Oslo study. Stroke. 2013; 24(10):1484-9.
11. Nagaraj SK, Pai P, Bhat G, Hemalatha A. Lipoprotein (a) and other lipid profile in patient swith thrombotic stroke: Isit a reliablemarker? J Lab Physicians. 2011; 3(1):2832.
12. LU H, Daugherty A. Atherosclerosis: cell biology and lipoproteins. Curr Opin Lipidol. 2011; 22:322-3.
13. Edjoc RK, Reid RD, Sharma M. Thee effectiveness of smoking cessation interventions in smokers with cerebrovascular disease: a systematic review. BMJ Open [Internet]. 2012 [citado 2017 Abr 19]; 2012(2):e002022. Disponible en: http://dx.doi.org/10.1136/bmjopen-2012-002022
14. Fowkes FG, Murray GD, Butcher I, Heald CL, Lee RJ, Chambless LE, et al. Ankle Brachial Index Collaboration. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA. 2013; 300:197-208.
15. Leyva Pérez Y, Soria Pérez R, Merencio Leyva N, Enamorado Suárez E, Herrera López Y. Caracterización clínico-epidemiológica de las enfermedades cerebrovasculares en el municipio Mayar. CCM. 2012 [citado 8 nov 2017]; 17(1): [aprox. 19 p.]. Disponible en: http://www.revcocmed.sld.cu/index.php/cocmed /article/viewFile/279/249
16. Ärnlöv J, Ingelsson E, Sundström J, Lind L. Impact of bodymassindex and the metabolic syndrome on the risk of cardiovascular disease and death in middle –aged men. Circulation. 2010; 121:230-6.
17. Lavados PM, Sacks C, Prina L, Escobar A, Tossi C, Araya F, et al. Prevalencia y factores de riesgo asociados a enfermedad cerebrovascular. Chile: a 2 year community based prospective study (PISCIS project). Lancet. 2015 [citado 8 nov 2017]; 365 (9478):2206-15.
18. Roiz Balaguer M, Morales Barrab I. Mortalidad por enfermedad cerebrovascular en el Hospital Julio Trigo López 2006. Rev Hab Cienc Med [Internet]. 2010 [citado 8 nov 2017]; 9 (1):19-26. Disponible en: http://scielo.sld.cu/pdf/rhcm/v9n1/rhcm05110.pdf
How to Cite
1.
Martínez Martin M, Álvarez Poveda JL, Roche Segura M, Portela V, Coelho G. Behavior of risk factors of cerebrovascular diseases, Pedras, Maranhão Brazil. Rev Inf Cient [Internet]. 2018 Jan. 16 [cited 2025 May 9];97(1):29-37. Available from: https://revinfcientifica.sld.cu/index.php/ric/article/view/1815
Issue
Section
Original Articles
